• English
  • 简体中文
Login Register
Current Location: Home > Marketing Drugs(EU) Feedback Help
EMA Approvals
-
HMA Approvals
-

EMA:Drugs approved by European Medicines Agency through centralized Procedure. 

HMA:Drugs approved by EU members through Mutual Recognition Procedure.

For more information check in official website of members:

Drug label information in UK

Public Assessment Reports in UK

Marketed drugs in France

Marketed drugs in Italy

Marketed drugs in Switzerland

Marketed drugs in Sweden

Marketed drugs in Germany

Click here for more information

Brand name Nonproprietary Name Authorization date Marketing authorisation holder
Toujeo (previously Optisulin) insulin glargine 2000-06-26 Sanofi-aventis Deutschland GmbH
Semglee insulin glargine 2018-03-23 Viatris Limited
Lantus insulin glargine 2000-06-09 sanofi-aventis Deutschland GmbH
Abasaglar (previously Abasria) insulin glargine 2014-09-09 Eli Lilly Nederland B.V.
Lusduna insulin glargine 2017-01-03 Merck Sharp & Dohme B.V.